Your browser doesn't support javascript.
loading
InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma.
Orlow, Irene; Sadeghi, Keimya D; Edmiston, Sharon N; Kenney, Jessica M; Lezcano, Cecilia; Wilmott, James S; Cust, Anne E; Scolyer, Richard A; Mann, Graham J; Lee, Tim K; Burke, Hazel; Jakrot, Valerie; Shang, Ping; Ferguson, Peter M; Boyce, Tawny W; Ko, Jennifer S; Ngo, Peter; Funchain, Pauline; Rees, Judy R; O'Connell, Kelli; Hao, Honglin; Parrish, Eloise; Conway, Kathleen; Googe, Paul B; Ollila, David W; Moschos, Stergios J; Hernando, Eva; Hanniford, Douglas; Argibay, Diana; Amos, Christopher I; Lee, Jeffrey E; Osman, Iman; Luo, Li; Kuan, Pei-Fen; Aurora, Arshi; Gould Rothberg, Bonnie E; Bosenberg, Marcus W; Gerstenblith, Meg R; Thompson, Cheryl; Bogner, Paul N; Gorlov, Ivan P; Holmen, Sheri L; Brunsgaard, Elise K; Saenger, Yvonne M; Shen, Ronglai; Seshan, Venkatraman; Nagore, Eduardo; Ernstoff, Marc S; Busam, Klaus J; Begg, Colin B.
Affiliation
  • Orlow I; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
  • Sadeghi KD; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
  • Edmiston SN; Department of Dermatology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Kenney JM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Lezcano C; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
  • Wilmott JS; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
  • Cust AE; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Scolyer RA; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Mann GJ; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.
  • Lee TK; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
  • Burke H; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Jakrot V; The Daffodil Centre, University of Sydney, a joint venture with Cancer Council New South Wales, Australia.
  • Shang P; Sydney School of Public Health, The University of Sydney, Sydney, Australia.
  • Ferguson PM; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Boyce TW; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Ko JS; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia.
  • Ngo P; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
  • Funchain P; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Rees JR; Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, New South Wales, Australia.
  • O'Connell K; John Curtin School of Medical Research, Australian National University, Canberra, Australia.
  • Hao H; British Columbia Cancer Research Center, Vancouver, British Columbia, Canada.
  • Parrish E; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Conway K; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Googe PB; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Ollila DW; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Moschos SJ; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and New South Wales Health Pathology, Sydney, New South Wales, Australia.
  • Hernando E; Department of Internal Medicine, University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, United States of America.
  • Hanniford D; Department of Pathology, Cleveland Clinic, Cleveland, Ohio, United States of America.
  • Argibay D; Department of Hospital Medicine, Cleveland Clinic, Cleveland, Ohio, United States of America.
  • Amos CI; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, United States of America.
  • Lee JE; Department of Epidemiology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America.
  • Osman I; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
  • Luo L; Department of Dermatology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Kuan PF; Department of Dermatology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Aurora A; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Gould Rothberg BE; Department of Dermatology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Bosenberg MW; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Gerstenblith MR; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Thompson C; Department of Dermatology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Bogner PN; Department of Surgery, Division of Surgical Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Gorlov IP; Department of Medicine, Division of Medical Oncology, The University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States of America.
  • Holmen SL; Department of Pathology, New York University Grossman School of Medicine, New York, New York, United States of America.
  • Brunsgaard EK; Department of Pathology, New York University Grossman School of Medicine, New York, New York, United States of America.
  • Saenger YM; Department of Pathology, New York University Grossman School of Medicine, New York, New York, United States of America.
  • Shen R; Department of Medicine, Baylor College of Medicine, Houston, Texas, United States of America.
  • Seshan V; Department of Surgical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Nagore E; Department of Urology, New York University Grossman School of Medicine, New York, NY, United States of America.
  • Ernstoff MS; Department of Medicine, New York University Grossman School of Medicine, New York, NY, United States of America.
  • Busam KJ; Department of Dermatology, New York University Grossman School of Medicine, New York, NY, United States of America.
  • Begg CB; Department of Internal Medicine, University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, United States of America.
PLoS One ; 18(4): e0269324, 2023.
Article in En | MEDLINE | ID: mdl-37011054
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nucleic Acids / MicroRNAs / Melanoma Type of study: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nucleic Acids / MicroRNAs / Melanoma Type of study: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2023 Document type: Article Affiliation country: Country of publication: